Loading...
Erlotinib treatment in pretreated patients with non-small cell lung cancer: A Phase II study
Erlotinib is an oral, small-molecule targeting therapy that inhibits epidermal growth factor tyrosine kinase receptors. Erlotinib has been administered for the treatment of advanced pancreatic cancer and non-small cell lung cancer. In the present trial, erlotinib was administered as second-line mono...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
D.A. Spandidos
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3436332/ https://ncbi.nlm.nih.gov/pubmed/22966304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol_00000059 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|